$22B+
Capital deployed '24–'26
2
Nobel Prizes (2024)
173+
AI drugs in trials
0
AI drugs FDA approved
0
AI materials at scale
MModel
VVertically Integrated
Foundation models (top) power application domains (middle), supported by infrastructure (bottom). Columns show funding stage: Non-Commercial (academic/open-source), Early Stage (pre-seed → Series A), Late Stage (Series B+, public, pharma). Hover any chip for details.
Category
Non-Commercial
Early Stage
Late Stage
Foundation Models
Protein & Molecular
Genomic & Sequence
Chemistry & Synthesis
Materials
Application Domains
Small Molecule Drug Discovery
Antibody, Biologics & Gene Therapy
Materials
MA
MARSShenzhenInfrastructure
Autonomous Labs & AI Scientists
Picks & Shovels
Field Maturity
Protein Structure▾
Protein Design▾
Small Molecule▾
Chemistry & Synthesis▾
Genomic Models▾
Materials & Energy▾
Autonomous Labs & Scientists▾
AI-Designed Drugs in Trials
Phase 3
GB-0895
AntibodyAsthma (anti-TSLP)Phase 2
Rentosertib
Small mol.Lung fibrosisPhase 1
ABS-201
AntibodyHair loss (anti-PRLR)Phase 1
ISM3091
Small mol.Solid tumors (USP1)Phase 1
REC-1245
Mol. glueSolid tumors (RBM39)Phase 1
IAM1363
Small mol.HER2 cancersLargest Rounds ('24 – '26)
$6.2BProject Prometheus - Bezos, physical AI
$1.0BXaira - no disclosed programs
$600MIsomorphic Labs - IsoDDE, $3B deals
$500MSandboxAQ - quantum + AI
$400MGenerate Bio - IPO filing
$372MFormation Bio - Sanofi + OpenAI
$350MLila Sciences - zero results
$300MPeriodic - Bezos, a16z
$180MOwkin - agentic biology, Anthropic
Topology Research - Work in progressFeedback? DMs open on XNot investment advice